Lombard Odier Asset Management (USA)’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.81M | Hold |
|
|||||
|
2025
Q1 | $4.04M | Sell |
|
|||||
|
2024
Q4 | $10.2M | Sell |
|
|||||
|
2024
Q3 | $36.2M | Buy |
|
|||||
|
2024
Q2 | $36.8M | Buy |
|
|||||
|
2024
Q1 | $41.6M | Sell |
|
|||||
|
2023
Q4 | $54.5M | Sell |
|
|||||
|
2023
Q3 | $33.7M | Sell |
|
|||||
|
2023
Q2 | $18.7M | Buy |
|
|||||
|
2023
Q1 | $20.7M | Buy |
|
|||||
|
2022
Q4 | $50.6M | Sell |
|
|||||
|
2022
Q3 | $35.7M | Buy |
|
|||||
|
2022
Q2 | $38.2M | Buy |
|
|||||
|
2022
Q1 | $55.7M | Buy |
|
|||||
|
2021
Q4 | $83M | Buy |
|
|||||
|
2021
Q3 | $10.7M | Sell |
|
|||||
|
2021
Q2 | $21.6M | Sell |
|
|||||
|
2021
Q1 | $24.4M | Buy |
|
|||||
|
2020
Q4 | $10.2M | Hold |
|
|||||
|
2020
Q3 | $8.1M | Buy |
|